Ventral Hernia News and Research

RSS

Covidien acquires PolyTouch Medical

PolyTouch Medical Ltd., a leading developer of hernia mesh placement technologies, was acquired by Covidien, a leading global provider of healthcare products that is traded on the New York Stock Exchange at a current market value of $26 billion.

30 Apr 2012

SafeStitch Medical's AMID Stapler to be presented at AHS 2012

SafeStitch Medical, Inc. will present the AMID Stapler® at the 5th International Hernia Congress in New York City, March 28-31, 2012.

29 Mar 2012

Synovis Life Technologies third quarter net revenue increases 19% to record $21.0 million

Synovis Life Technologies, Inc., today reported its financial results for the fiscal third quarter ended July 31, 2011.

24 Aug 2011

Covidien's PCOx mesh receives U.S. FDA 510(k) clearance and European CE Mark approval

Covidien, a leading global provider of healthcare products, today announced that the U.S. Food and Drug Administration has granted 510(k) clearance and the European regulatory authorities have granted the CE Mark to Parietex Optimized Composite mesh.

2 Jun 2011

Covidien to present new data on hernia, abdominal wall repair products at San Francisco

Covidien, a leading global provider of healthcare products, announced that new data on its hernia and abdominal wall repair products will be presented at Hernia Repair 2011, the 14th Annual Meeting & Scientific Program of the American Hernia Society.

15 Mar 2011

2011 Clinical Congress of American College of Surgeons to take place in October, in San Francisco

The 2011 Clinical Congress of the American College of Surgeons—one of the largest international meetings of surgeons in the world—will convene October 23-27, 2011, in San Francisco, CA. The San Francisco Hilton will serve as the headquarters hotel for the meeting, and the Moscone Convention Center will house the scientific panel sessions and courses, as well as all scientific and technical exhibits.

19 Feb 2011

New report evaluates rate of reinterventions, readmissions after initial AAA surgery

A new report published in the January issue of the Journal of Vascular Surgery® evaluates the rate of reinterventions and readmissions after initial abdominal aortic aneurysm repair, 30-day mortality and the effect on long-term survival.

30 Dec 2010

Biomerix enters distribution agreement with Medline

Biomerix Corporation, a medical technology company developing and manufacturing innovative hernia repair products, today announced that it has entered into an exclusive distribution agreement with Medline Industries, Inc., the nation's largest privately held manufacturer and distributor of medical and surgical products in the United States.

25 Oct 2010

Covidien presents hernia and abdominal wall repair products at EHS Meeting

Covidien, a leading global provider of healthcare products, announced that its hernia and abdominal wall repair products were featured in 18 podium presentations at the 32nd International Congress of the European Hernia Society (EHS).

12 Oct 2010

PolyTouch Medical raises US $830k in private financing round

PolyTouch Medical Ltd., a leading developer of laparoscopic soft tissue prosthetic placement technologies, announced today that the Company has raised US $830k in a private financing round.

27 Sep 2010

Biomerix receives FDA 510(k) Clearance to market Ventral Hernia Repair Mesh

Biomerix Corporation announced today that it has received U.S. Food and Drug Administration 510(k) Clearance to market its Biomerix Ventral Hernia Repair Mesh, the latest addition to its innovative portfolio of soft tissue repair devices. The Biomerix Ventral Hernia Repair Mesh, with two distinctly different sides, is the first and only device featuring the Biomerix Biomaterial on one side, designed to promote tissue ingrowth, and a resorbable protective film on the other side, designed to minimize tissue attachment to the device in case of direct contact with the viscera.

1 Jul 2010

PolyTouch Medical's PatchAssist device receives FDA clearance

PolyTouch Medical Ltd., a leading developer of laparoscopic soft tissue prosthetic placement technologies, today announced that it has received broad FDA 510(k) clearance to commercialize PatchAssist. PatchAssist is an innovative laparoscopic surgical instrument that enables accurate and rapid delivery and placement of soft tissue prosthetics for a variety of procedures, including laparoscopic ventral hernia repair.

21 Jun 2010

Synovis Life Technologies' second-quarter 2010 net revenue up 19%

Synovis Life Technologies, Inc., today reported record revenue for the second quarter ended April 30, 2010.

26 May 2010

PolyTouch Medical files Premarket 510(k) application for PatchAssist laparoscopic mesh deployment device

PolyTouch Medical Ltd., a leading developer of laparoscopic hernia mesh placement technologies, today announced that it has filed a Premarket 510(k) Application with the US Food and Drug Administration for PatchAssist, an Innovative Laparoscopic Mesh Deployment and Placement Device that enables accurate mesh placement in laparoscopic ventral hernia repair potentially reducing procedure time by 30%-50%.

3 May 2010

SAGES 2010: Covidien to showcase technological advancements in bariatric, colorectal and hernia surgery

Covidien, a leading global provider of healthcare products, will preview a variety of new devices and showcase some of the Company's most innovative tools for endoscopic surgery and soft tissue repair at the 2010 Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) annual meeting held here.

13 Apr 2010

Synovis Life Technologies reports net revenue of $15.2M for first-quarter fiscal 2010

Synovis Life Technologies, Inc., today reported financial results for the first fiscal quarter ended Jan. 31, 2010.

24 Feb 2010

ULTRACET® Effective And Well Tolerated For Post-Surgical Pain

A new study published in the latest edition of a leading medical journal has shown that treatment with ULTRACET® (37.5 mg tramadol hydrochloride/325 mg acetaminophen tablets) demonstrates similar efficacy and better tolerability than TYLENOL® with Codeine No. 3 when each is compared to placebo.

5 Apr 2004